Navin Kapur, M.D., FAHA, FACC, FSCAI, director, Acute Mechanical Circulatory Support Program and executive director of The...
Intra-Aortic Balloon Pumps (IABP)
This channel includes news and new technology innovations for intra-aortic balloon pumps (IABP). IABPs are a type of hemodynamic support device that is inserted into the aorta to help the heart pump blood.
-
-
November 19, 2019 — Since Maquet/Datascope first recalled all of its intra-aortic balloon pumps (...
-
-
A discussion with William O'Neill, M.D., director of the structural heart program, Henry Ford Hospital...
Videos | Hemodynamic Support Devices | January 24, 2020
Navin Kapur, M.D., FAHA, FACC, FSCAI, director,...
News | November 19, 2019
November 19, 2019 — Since Maquet/Datascope first recalled all of its ...
Feature | Intra-Aortic Balloon Pumps (IABP) | July 24, 2019
July 24, 2019 — The U.S. Food and Drug Administration announced Maquet/Datascope is recalling all...
The Abiomed Impella percutaneous heart pump during a procedure at Henry Ford Hospital.
Podcast | Hemodynamic Support Devices | May 02, 2019
This podcast is a discussion with ...
News | Intra-Aortic Balloon Pumps (IABP) | November 05, 2018
November 5, 2018 — The U.S. Food and Drug Administration (FDA) is evaluating recent reports of Getinge's Maquet/...
News | Intra-Aortic Balloon Pumps (IABP) | September 24, 2018
Getinge Issues Worldwide Voluntary Correction of Maquet/Getinge Cardiosave Intra-Aortic Balloon Pump
September 24, 2018 — Getinge is voluntarily initiating a worldwide recall involving a field correction of...
Two versions of the Abiomed Impella percutaneous ventricular assist device displayed at ACC 2018. Impella is the only device that currently has a FDA indication for use in cardiogenic shock.
Feature | Hemodynamic Support Devices | July 08, 2018 | Emmanouil S. Brilakis, M.D., Ph.D., FSCAI and Srihari S. Naidu, M.D., FSCAI
Cardiogenic shock (CS) is a low-cardiac-output state resulting in life-threatening end-organ hypoperfusion and hypoxia...
William O'Neill, M.D., unveils the Detroit Cardiogenic Shock Initiative at Henry Ford Hospital. The program uses new protocols to reduce cardiogenic shock mortality by 50 percent by using early hemodyanmic support.
Feature | Hemodynamic Support Devices | June 22, 2018 | Dave Fornell, Editor
About 50 percent of patients in cardiogenic shock do not survive, and account for about 90,000 heart attack patients...
The touchscreen Maquet Datascope CardioSave Hybrid Intra-aortic Balloon Pump (IABP) system console.
News | Intra-Aortic Balloon Pumps (IABP) | June 06, 2018
June 6, 2018 — Maquet Datascope Corp. said it is recalling the CardioSave Hybrid Intra-aortic Balloon Pump (IABP)...
An example of an intra-aortic balloon pump (IABP) from Maquet.
Feature | Intra-Aortic Balloon Pumps (IABP) | May 31, 2018
May 31, 2018 — The results from the Survival Improvement in Extensive Myocardial Infarction with PERsistent Ischemia...
The Datascope CS300 IABP console.
News | Hemodynamic Support Devices | June 20, 2017
June 20, 2017 — The U.S. Food and Drug Administration (FDA) said Maquet/Datascope is voluntarily performing a...
Technology | Intra-Aortic Balloon Pumps (IABP) | May 02, 2017
May 2, 2017 — The U.S. Food and Drug Administration (FDA) granted 510(k) clearance for the Teleflex Inc. AC3 Optimus...
News | Intra-Aortic Balloon Pumps (IABP) | January 03, 2017 | Dave Fornell
January 3, 2017 — The Impella CP heart pump (Abiomed) demonstrated no improvement in mortality for patients with...
